Maxcyte (MXCT) Intangibles (2025 - 2026)
Maxcyte (MXCT) reported Intangibles of $783000.0 for Q1 2026, up 11.38% year-over-year from $703000.0 in Q1 2025, and up 20.46% quarter-over-quarter from $650000.0 in Q4 2025.
Maxcyte (MXCT) Intangibles (2025 - 2026) Analysis & Trends
Maxcyte (MXCT) has 2 years of Intangibles data on file, last reported at $783000.0 in Q1 2026.
- Intangibles for Q1 2026 came in at $783000.0, up 11.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $783000.0 (up 11.38% YoY), and the FY2025 annual result was $650000.0, changed N/A from the prior year.
- Intangibles improved to $783000.0 in Q1 2026 per MXCT's latest filing, from $650000.0 in the prior quarter.
- Over five years, Intangibles peaked at $783000.0 in Q1 2026 and troughed at $638000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.88 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 5.52 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 10.34 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 7.06 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 1.23 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.14 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 62.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 1.91 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.62 Bn |
| 10 | Maxcyte | 127.72 Mn | 127.72 Mn | 8.08 Mn | 783,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 783,000.00 |
| Dec 31, 2025 | 650,000.00 |
| Sep 30, 2025 | 667,000.00 |
| Jun 30, 2025 | 638,000.00 |
| Mar 31, 2025 | 703,000.00 |